Oruka Therapeutics CMO Joana Goncalves Sells $707K of Stock
Joana Goncalves, CMO, sold 7,000 shares of Oruka Therapeutics, Inc. at $99.52 to $105.86 a share (average $100.96) in 6 transactions, worth $707K in total on Nov 16, 2026. Shares held after the trade: 31,771 (-1.5%).
Oruka Therapeutics SVP, Finance Arjun Agarwal Sells $1.05M of Stock
Arjun Agarwal, SVP, Finance, sold 10,000 shares of Oruka Therapeutics, Inc. at $101.98 to $107.00 a share (average $104.97) in 6 transactions, worth $1.05M in total on Nov 12, 2026. Shares held after the trade: 14,219 (-0.7%).
Oruka Therapeutics Insider Kristine M. Ball Sells $1.89M of Stock
Kristine M. Ball sold 18,000 shares of Oruka Therapeutics, Inc. at $102.10 to $106.98 a share (average $104.93) in 6 transactions, worth $1.89M in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).
Oruka Therapeutics CEO Lawrence Otto Klein Sells $2.39M of Stock
Lawrence Otto Klein, CEO, sold 25,000 shares of Oruka Therapeutics, Inc. at $94.77 to $98.40 a share (average $95.60) in 5 transactions, worth $2.39M in total on Nov 2, 2026. Shares held after the trade: 923,128 (-0.0%).
Oruka Therapeutics General Counsel Paul T. Quinlan Sells $707K of Stock
Paul T. Quinlan, General Counsel, sold 9,000 shares of Oruka Therapeutics, Inc. at $74.90 to $79.49 a share (average $78.53) in 5 transactions, worth $707K in total on Oct 20, 2026. Shares held after the trade: 29,995 (-9.1%).
Oruka Therapeutics CMO Joana Goncalves Sells $524K of Stock
Joana Goncalves, CMO, sold 7,000 shares of Oruka Therapeutics, Inc. at $73.89 to $77.71 a share (average $74.81) in 5 transactions, worth $524K in total on Oct 15, 2026. Shares held after the trade: 31,771 (-0.6%).
Oruka Therapeutics SVP, Finance Arjun Agarwal Sells $806K of Stock
Arjun Agarwal, SVP, Finance, sold 9,999 shares of Oruka Therapeutics, Inc. at $80.03 to $82.83 a share (average $80.60) in 4 transactions, worth $806K in total on Oct 12, 2026. Shares held after the trade: 14,219 (-1.4%).
Oruka Therapeutics CEO Lawrence Otto Klein Sells $2.09M of Stock
Lawrence Otto Klein, CEO, sold 25,000 shares of Oruka Therapeutics, Inc. at $83.40 to $84.78 a share (average $83.62) in 3 transactions, worth $2.09M in total on Oct 1, 2026. Shares held after the trade: 923,128 (-0.0%).
Oruka Therapeutics SVP, Finance Arjun Agarwal Sells $51K of Stock
Arjun Agarwal, SVP, Finance, sold 533 shares of Oruka Therapeutics, Inc. at $95.75 a share, worth $51K in total on Sep 21, 2026. Shares held after the trade: 14,219 (-3.6%).
Oruka Therapeutics General Counsel Paul T. Quinlan Sells $936K of Stock
Paul T. Quinlan, General Counsel, sold 10,000 shares of Oruka Therapeutics, Inc. at $92.37 to $95.31 a share (average $93.64) in 4 transactions, worth $936K in total on Sep 21, 2026. Shares held after the trade: 29,995 (-8.2%).